Sentinel Lymph Node Biopsy: Understanding Its Role in Cancer Diagnosis

The sentinel lymph node (SLN) is the first node receiving lymphatic drainage from a primary tumor. SLN biopsy is crucial for cancer staging and management:

• Early Metastasis Detection: Identifies spread to regional nodes, guiding staging and treatment.
• Treatment Decisions: Positive SLN indicates higher spread risk; may prompt axillary dissection or adjuvant chemo.
• Surgical Guidance: Negative SLN can avoid extensive dissection, reducing lymphedema risk.
• Treatment Monitoring: Pre/post-neoadjuvant therapy SLN comparison assesses response.
• Prognostic Value: Negative SLN correlates with better prognosis, lower recurrence risk.

SLN biopsy enhances accuracy and effectiveness of cancer treatment.